Fundacion Rioja Salud

Running trials

• Recruiting

  A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  NCT07503808· Phase 1· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  NCT07288177· Phase 2· Source

• Recruiting

  A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

  NCT07227597· Phase 1/2· Source

• Recruiting

  Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  NCT07402915· Phase 1· Source

• Recruiting

  A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

  NCT07226427· Phase 1· Source

• Recruiting

  Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

  NCT07246863· Phase 2· Source

• Recruiting

  DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  NCT06953089· Phase 2· Source

• Recruiting

  A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT06907615· Phase 2· Source

• Recruiting

  Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

  NCT06458712· Phase 1· Source

• Recruiting

  FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  NCT06303505· Phase 1/2· Source

• Recruiting

  Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  NCT05997615· Phase 1· Source

• Recruiting

  Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

  NCT04953910· Phase 1· Source

• Recruiting

  Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

  NCT05533697· Phase 1/2· Source

• Recruiting

  Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

  NCT04953897· Phase 1· Source

• Recruiting

  Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors

  NCT04855656· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer7 recruiting
• Ovarian cancer6 recruiting
• Prostate cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Head and neck cancer2 recruiting
• Myelodysplastic syndromes2 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· Phase 2· Source